Hosier, G. W.; Touma, N. J. Response of Renal Cell Carcinoma to Ibrutinib, a Bruton Tyrosine Kinase Inhibitor, in a Patient Treated for Chronic Lymphocytic Leukemia. CUAJ 2017, 11, E237-9.